Intrinsic Value of S&P & Nasdaq Contact Us

Cannabis Suisse Corp. CSUI OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
14/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cannabis Suisse Corp. (CSUI) generated $-45.11K in operating cash flow for fiscal year 2025. After capital expenditures of $0.00, free cash flow was $-45.11K.

Free cash flow margin was -200.5% of revenue. Cash conversion ratio was 0.1x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (0/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was 0.1x suggests some earnings are non-cash items

Overall SharesGrow Score: 13/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
14/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Cannabis Suisse Corp. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $-52.5K$-45.11K$-45.64K$-163.96K$-32.09K
Capital Expenditure $-5.00$0.00$-3.00$0.00$0.00
Free Cash Flow $-52.51K$-45.11K$-45.64K$-163.96K$-32.09K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message